Cell-specific regulation of gene expression using splicing-dependent frameshifting
-
Published:2022-10-01
Issue:1
Volume:13
Page:
-
ISSN:2041-1723
-
Container-title:Nature Communications
-
language:en
-
Short-container-title:Nat Commun
Author:
Ling Jonathan P.ORCID, Bygrave Alexei M., Santiago Clayton P.ORCID, Carmen-Orozco Rogger P.ORCID, Trinh Vickie T., Yu Minzhong, Li YiniORCID, Liu Ying, Bowden Kyra D., Duncan Leighton H., Han JeongORCID, Taneja Kamil, Dongmo Rochinelle, Babola Travis A., Parker Patrick, Jiang Lizhi, Leavey Patrick J.ORCID, Smith Jennifer J., Vistein Rachel, Gimmen Megan Y., Dubner Benjamin, Helmenstine Eric, Teodorescu PatricORCID, Karantanos Theodoros, Ghiaur GabrielORCID, Kanold Patrick O.ORCID, Bergles DwightORCID, Langmead BenORCID, Sun Shuying, Nielsen Kristina J.ORCID, Peachey NealORCID, Singh Mandeep S., Dalton W. Brian, Rajaii FatemehORCID, Huganir Richard L.ORCID, Blackshaw SethORCID
Abstract
AbstractPrecise and reliable cell-specific gene delivery remains technically challenging. Here we report a splicing-based approach for controlling gene expression whereby separate translational reading frames are coupled to the inclusion or exclusion of mutated, frameshifting cell-specific alternative exons. Candidate exons are identified by analyzing thousands of publicly available RNA sequencing datasets and filtering by cell specificity, conservation, and local intron length. This method, which we denote splicing-linked expression design (SLED), can be combined in a Boolean manner with existing techniques such as minipromoters and viral capsids. SLED can use strong constitutive promoters, without sacrificing precision, by decoupling the tradeoff between promoter strength and selectivity. AAV-packaged SLED vectors can selectively deliver fluorescent reporters and calcium indicators to various neuronal subtypes in vivo. We also demonstrate gene therapy utility by creating SLED vectors that can target PRPH2 and SF3B1 mutations. The flexibility of SLED technology enables creative avenues for basic and translational research.
Funder
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health U.S. Department of Health & Human Services | NIH | National Eye Institute Research to Prevent Blindness
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary
Reference92 articles.
1. Liu, Y., Hegarty, S., Winter, C., Wang, F. & He, Z. Viral vectors for neuronal cell type-specific visualization and manipulations. Curr. Opin. Neurobiol. 63, 67–76 (2020). 2. Weissleder, R., Kelly, K., Sun, E. Y., Shtatland, T. & Josephson, L. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat. Biotechnol. 23, 1418–1423 (2005). 3. Bedbrook, C. N., Deverman, B. E. & Gradinaru, V. Viral Strategies for Targeting the Central and Peripheral Nervous Systems. Annu Rev. Neurosci. 41, 1–26 (2018). 4. Dimidschstein, J. et al. A viral strategy for targeting and manipulating interneurons across vertebrate species. Nat. Neurosci. 19, 1743–1749 (2016). 5. Leeuw, C. Nde et al. rAAV-compatible MiniPromoters for restricted expression in the brain and eye. Mol. Brain 9, 52 (2016).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|